7bd7
From Proteopedia
Jump to navigationJump to search
X-ray structure of Arsenoplatin-1-encapsulated horse spleen ferritin
| ||||||||||||
Structural highlights
Publication Abstract from PubMedArsenoplatin-1 (AP-1), the prototype of a novel class of metallodrugs containing a PtAs(OH)2 core, was encapsulated within the apoferritin (AFt) nanocage. UV-Vis absorption spectroscopy and inductively coupled plasma-atomic emission spectroscopy measurements confirmed metallodrug encapsulation and allowed us to determine the average amount of AP-1 trapped inside the cage. The X-ray structure of AP-1-encapsulated AFt was solved at 1.50 A. Diffraction data revealed that an AP-1 fragment coordinates the side chain of a His residue. The biological activity of AP-1-loaded AFt was comparatively tested on a few representative cancer and non-cancer cell lines. Even though the presence of the cage reduces the overall cytotoxicity of AP-1, it improves its selectivity towards cancer cells. Arsenoplatin-Ferritin Nanocage: Structure and Cytotoxicity.,Ferraro G, Pratesi A, Cirri D, Imbimbo P, Maria Monti D, Messori L, Merlino A Int J Mol Sci. 2021 Feb 13;22(4). pii: ijms22041874. doi: 10.3390/ijms22041874. PMID:33668605[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See AlsoReferences
| ||||||||||||||||||||
This page was last modified 19:00, 8 September 2026.